Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis.
Cerebrospinal fluid (CSF) free light chains of kappa or lambda (FLC kappa/lambda) type were investigated by affinity mediated blotting technique (AMI) and ELISA in 28 patients of which nine with AIDS and Toxoplasma gondii encephalitis (AIDS, TE), 11 with AIDS with or without other CNS AIDS-related opportunistic infections (non-TE AIDS) and eight control patients with or without inflammatory neurological disorders (control group). CSF restricted oligoclonal FLC bands either of k or lambda isotype or both were found by AMI in 18 (90%) out of 20 AIDS patients, while a CSF pattern predominantly characterized by FkappaLC rather than FlambdaLC was observed in eight (88.8%) out of nine TE patients. No FLC components were detected in the matched sera of TE or non-TE AIDS patients or in the CSF and sera from control group. The anti-parasite-specific FkappaLC CSF/serum mean levels and the T. gondii-specific FkappaLC index values were found by ELISA to be significantly more elevated in TE patients when compared to non-TE AIDS or control group. These findings suggest that the increased production of T. gondii-specific FkappaLC could provide insights into pathogenesis of reactivated TE in immunocompromised patients and may have important diagnostic usefulness.
Contini
C
C
Section of Infectious Diseases, Department of Clinical and Experimental Medicine, Via Fossato di Mortara 23, University of Ferrara, I-44100, Ferrara, Italy. cnc@ifeuniv.unife.it
Fainardi
E
E
Cultrera
R
R
Seraceni
S
S
Castellazzi
M
M
Peyron
F
F
Granieri
E
E
D017088:AIDS-Related Opportunistic Infections / Q000134:cerebrospinal fluid / Q000150:complications / Q000276:immunology / Q000469:parasitology; D000163:Acquired Immunodeficiency Syndrome / Q000134:cerebrospinal fluid* / Q000150:complications* / Q000276:immunology / Q000469:parasitology; D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology; D000918:Antibody Specificity; D004660:Encephalitis / Q000134:cerebrospinal fluid* / Q000150:complications* / Q000276:immunology / Q000469:parasitology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000097:blood / Q000134:cerebrospinal fluid* / Q000276:immunology*; D007146:Immunoglobulin lambda-Chains / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology; D008297:Male; D016555:Matched-Pair Analysis; D014122:Toxoplasma / Q000276:immunology* / Q000502:physiology; D016781:Toxoplasmosis, Cerebral / Q000134:cerebrospinal fluid / Q000150:complications / Q000276:immunology / Q000469:parasitology
D000913:Antibodies, Protozoan; D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains